FITB vs SION
Fifth Third Bancorp (FITB) versus Sionna Therapeutics, Inc. Common Stock (SION) — a side-by-side from cached financials, not a winner call.
Fifth Third Bancorp (FITB) is a banks - regional company listed on US.
Sionna Therapeutics, Inc. Common Stock (SION) is a biotechnology company listed on US.
Latest reported FITB revenue for 2026-06-30 was $3.37B. Net income was $801.0M. Revenue was up 13.5% from 2026-03-31 to 2026-06-30. FITB currently screens at market cap $45.25B and trailing P/E 16.8.
SION does not have a complete income-statement cache yet.
FITB currently screens at market cap $45.25B and trailing P/E 16.8. SION currently screens at market cap $0.
Not investment advice. Open the FITB and SION stock pages for the full models.
Not investment advice.